Back to top of page

NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)

1. Name of the researcher or research team applying for the grant

2. Contact information for the researcher or research team

3. Research experience of the applicant, both in basic and clinical research

4. Description of the research discoveries related to the treatment of Substance Use Disorders

5. Description of how the research discoveries will be translated into medications for SUDs

6. Processes and methods to develop molecules with the potential to treat SUDs

7. Description of the drug development continuum and how the research will advance molecules within it

8. Previous achievements or milestones in the field of SUD treatment

9. Plan for obtaining FDA approval for the developed molecules

10. Timeline for the project and key milestones to be achieved

11. Budget breakdown and justification for the requested funds

12. Any collaborations or partnerships with other institutions or researchers for the project

13. Any additional supporting materials or documentation relevant to the application

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows